Edition:
United Kingdom

GNI Group Ltd (2160.T)

2160.T on Tokyo Stock Exchange

570JPY
24 Nov 2017
Change (% chg)

¥18 (+3.26%)
Prev Close
¥552
Open
¥553
Day's High
¥574
Day's Low
¥549
Volume
6,262,000
Avg. Vol
6,841,568
52-wk High
¥938
52-wk Low
¥172

Summary

Name Age Since Current Position

Ying Luo

48 2010 President, Representative Executive Officer, Chief Executive Officer, Chairman and CEO of Subsidiaries, Director

Thomas Eastling

59 2015 Chief Financial Officer, Representative Executive Officer, Director

Takashi Kataoka

77 2013 Director

Sadayuki Yasukawa

66 2011 Director

Wanshou Guo

53 2010 Independent Director

Hideaki Sashiwa

55 2008 Independent Director

Liwen Wu

66 2010 Independent Director

Shinobu Tanaka

IR Contact Officer

Biographies

Name Description

Ying Luo

Dr. Ying Luo has been serving as President, Representative Executive Officer, Chief Executive Officer and Director in GNI Group Ltd., as well as Chairman of the Board and CEO of two subsidiaries, Shanghai Genomics, Inc. and GNI-EPS Pharmaceuticals, Inc., and Chairman of the Board in another subsidiary, Beijing Continent Pharmaceutical Co., Ltd., since September 2011. He used to serve as Managing Director and Chief Operating Officer in the Company. He used to work for three other companies. He obtained his Doctor's degree in Science from University of Connecticut in 1991.

Thomas Eastling

Mr. Thomas Eastling has been serving as Chief Financial Officer, Representative Executive Officer and Director in GNI Group Ltd. March 26, 2015. He used to work for The Nikko Securities Co. International, Inc., Duff & Phelps Credit Rating Co. (now called Fitch Ratings Ltd.) and Softbank Commerce Corp.

Takashi Kataoka

Mr. Takashi Kataoka has been serving as Director in GNI Group Ltd. since July 1, 2013. He is also serving as Director in three subsidiaries, Shanghai Genomics, Inc., GNI-EPS Pharmaceuticals, Inc. and Beijing Continent Pharmaceutical Co., Ltd. He joined the Company in November 2005. He previously served as Chief Administrating Officer of the Company. He used to work for other companies, such as Mitsui & Co., Ltd., Iran-Japan Petrochemical Company and Daicolor-Pope, Inc.

Sadayuki Yasukawa

Mr. Sadayuki Yasukawa has been serving as Director of GNI Group Ltd. since March 2011. He is also serving as Auditor in a Shanghai-based company. He used to work for MITSUI & CO., LTD. and another company that is under the new name Mitsui Marubeni Liquefied Gas Co. Ltd. He also used to serve as Chief Financial Officer and Director of two subsidiaries of MITSUI & CO., LTD.

Wanshou Guo

Mr. Wanshou Guo has been serving as Independent Director in GNI Group Ltd. since March 2010. He is also working for China-Japan Friendship Hospital.

Hideaki Sashiwa

Mr. Hideaki Sashiwa has been serving as Independent Director in GNI Group Ltd. since June 2008. He is also serving as Vice President and Director in GI Capital Securities Ltd., as well as President and Representative Director in another company. He is also working for JP Holdings Group and Shanghai Genomics, Inc. as an auditor. He used to work for Daiwa Securities Co., Ltd. and NIKKATSU Corporation.

Liwen Wu

Mr. Liwen Wu has been serving as Independent Director in GNI Group Ltd. since March 2010. He is also working for Peking Union Medical College Hospital as Chief Doctor & Professor and Ph.D. Advisor.

Shinobu Tanaka